Take Advantage Of The ‘Summer Dip’ With The FTSE 100, AstraZeneca plc & Vodafone Group plc

Now could be a great time to buy AstraZeneca plc (LON: AZN), Vodafone Group plc (LON: VOD) and the FTSE 100 (INDEXFTSE:UKX).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

FTSE100

‘Sell in May and don’t come back until St. Ledger’s day’ is a well-known saying in investing circles. Indeed, data from recent decades seems to back it up: the stock market rarely embarks on a sustained summer rally and usually falls between May and September. This has been the case in 2014, with the FTSE 100 falling by 1% over the last three months.

This means that the index is flat for the year so far, although it still appears to offer good value for money when compared to its American cousin, the S&P 500. While it trades on a price to earnings (P/E) ratio of 18.5, our FTSE 100 has a P/E of just 13.4. So, while many commentators have been getting excited about our ‘summer dip’ in terms of it being the beginning of a prolonged market correction, it could turn out to be little more than a mild, mundane and entirely predictable summer pullback.

Great Value

As a result of falls in the last few months, many top-notch FTSE 100 stocks are now even better value than they were in May. Two fine examples are AstraZeneca (LSE: AZN) and Vodafone (LSE: VOD). The former has fallen by 1.5% during the last three months, while the latter is down 7% over the same time period. This means that both companies now offer above-average yields of 4% and 5.7% respectively, which highlights their attractive valuations at current price levels.

Looking Ahead

However, there is a lot more to AstraZeneca and Vodafone that attractive prices. For example, AstraZeneca continues to make huge improvements to its drug pipeline and is gradually overcoming a sizeable patent cliff that has caused the company’s top and bottom lines to fall in recent years. Similarly, Vodafone is pursuing a sound strategy of buying undervalued assets in Europe. Although it may take many years for this strategy to come good, it looks set to put Vodafone on a long term path to strong growth and stability, which is great news for shareholders.

Certainly, the ‘summer dip’ may not yet be over. The FTSE 100, including AstraZeneca and Vodafone, may fall further. However, they seem to offer top notch value for money at present and appear to have bright futures. Indeed, with the UK economy continuing to pick up pace, and with interest rates looking less likely to move higher as a result of lower than expected inflation, a purple patch could be just around the corner. As a result, it could be worth coming back a little before St. Ledger’s day!

Peter Stephens owns shares of AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

The best time to buy stocks? It might be right now

Short-term issues that delay long-term trends create opportunities to buy stocks. And that could be happening right now with a…

Read more »

Queen Street, one of Cardiff's main shopping streets, busy with Saturday shoppers.
Investing Articles

Here’s why Next stock rose 5% and topped the FTSE 100 today

Next was the leading FTSE 100 stock today, rising 5%. Our writer takes a look at why and asks if…

Read more »

Renewable energies concept collage
Investing Articles

Up 458% in a year, could the Ceres Power share price go even higher?

Christopher Ruane reviews some highs and lows of the Ceres Power share price over the years and wonders whether the…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Are the glory days over for Rolls-Royce shares?

Rolls-Royce shares have soared in recent years. Lately, though, they have taken a tumble. Could there be worse still to…

Read more »

Group of friends meet up in a pub
Investing Articles

Are ‘66% off’ Diageo shares a once-in-a-decade opportunity?

Diageo shares have taken another hit in the early weeks of 2026. Are we looking at a massive bargain or…

Read more »

Investing Articles

Meet the UK stock under £1.50 smashing Rolls-Royce shares over the past year

While Rolls-Royce shares get all the attention, this under-the-radar trust has quietly made investors a fortune. But is it still…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

Down 19%, the red lights are flashing for Barclays shares!

Barclays shares have fallen almost a fifth in value as the Middle East war has intensified. Royston Wild argues that…

Read more »

Aviva logo on glass meeting room door
Investing Articles

After falling another 5%, are Aviva shares too cheap to ignore?

£10,000 invested in Aviva shares five years ago would have grown 50% by now. But what might the future hold,…

Read more »